D. Rozman was a Head of the Organizing and Scientific Committee of the 15th International Conference on Cytochromes P450: Biochemistry, Biophysics and Functional Genomics, June 17–21, 2007, Bled, Slovenia. This international biannual meeting of scientists from the cytochrome P450 research field was organized in Slovenia for the first time. The cytochromes P450 superfamily includes major drug metabolizig enzymes in mammals and also several endogenouse enzymes involved in cholesterol, bile acid, steroid hormones and vitamin D synthesis. The meeting hosted over 300 participants from 32 countries.
B.01 Organiser of a scientific meeting
COBISS.SI-ID: 233480448Group members acting at NIC are for years part of a mixed research team with scientists from the pharmaceutical company Lek d.d., Biopharmacy: these contracts are among the largest contracts signed in Slovenia between economy sector and research institutions. This collaboration brought formation of the leading developmental staff in LEK in the field of biopharmacy (in 2007 Novartis inaugurated its new R&D centre for biopharmaceuticals in Slovenia), as well as development and technology transfer for production of recombinant proteins, accepted into production within the group Sandoz-Novartis.
F.13 Development of new production methods and tools or processes
COBISS.SI-ID: 3883802In 2005 we inaugurated, in a consortium of 14 partner institutions, the Centre for Functional Genomics na Bio-chips, a national centre operating as an open research instution for all Consortium members. Building and running the CFGBC can be considered as the first success in efforts of the CoE Biotechnology with Pharmacy (Head R. Komel), founded in 2004 following the call of the Governement of Slovenia for funding research infrastructure through European Funds for Regional Development (EFRD).
D.07 Presiding over a centre/laboratory
COBISS.SI-ID: 2802970In the period 2004-08 we published 10 international patents and 5 patent applications, from the fields of design, production, purification and formulation of biopharmaceuticals as well as inhibitors of cholesterol biosynthesis.
F.32 International patent
COBISS.SI-ID: 3015194Programme leader R. Komel was heading the governmental Comission for legal and ethical regulation of gene technology in Slovenia which elaborated the Law for Handling GSO. At present he is heading the Scientific board for handling with GMOs (at the Ministry for Environment) which also includes active contribution of some members of our programme group. R. Komel is also heading the national Commission for gene technology.
F.34 Consultancy
COBISS.SI-ID: 2378616